• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system.

作者信息

Porta Camillo

机构信息

Dept. of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Pavia, Italy.

出版信息

ESMO Open. 2020 May;5(3):e000790. doi: 10.1136/esmoopen-2020-000790.

DOI:10.1136/esmoopen-2020-000790
PMID:32366508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7211062/
Abstract
摘要

相似文献

1
Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system.社论辩论：在全民医疗体系下，肿瘤学家在新冠疫情期间必须面对的挑战。
ESMO Open. 2020 May;5(3):e000790. doi: 10.1136/esmoopen-2020-000790.
2
Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times.编辑辩论：在全民医疗体系下工作的我们肿瘤学家在这些艰难时期必须面对的挑战。
ESMO Open. 2020 May;5(3):e000800. doi: 10.1136/esmoopen-2020-000800.
3
COVID-19 experience in Bergamo, Italy.意大利贝加莫的新冠肺炎经历。
Eur Heart J. 2020 May 14;41(19):1783-1784. doi: 10.1093/eurheartj/ehaa279.
4
The ethical challenges of the SARS-CoV-2 pandemic in the global south and the global north - same and different.新冠疫情在全球南方和北方面临的伦理挑战——相同与不同之处。
Dev World Bioeth. 2020 Jun;20(2):62-64. doi: 10.1111/dewb.12263.
5
What if the worst consequences of COVID-19 concerned non-COVID patients?如果 COVID-19 最严重的后果涉及非 COVID 患者，该怎么办？
J Infect Public Health. 2020 Sep;13(9):1237-1239. doi: 10.1016/j.jiph.2020.06.014. Epub 2020 Jun 15.
6
Will Jordan be closer to UHC after the COVID-19 pandemic?新冠疫情后，约旦会更接近全民健康覆盖吗？
J Glob Health. 2020 Dec;10(2):020360. doi: 10.7189/jogh.10.020360.
7
Insights from Italy: the Novara-COVID Score for rapid destination of COVID-19 patients at Emergency Department presentation.来自意大利的见解：用于急诊科就诊时新冠病毒疾病患者快速分流的诺瓦拉新冠评分。
Minerva Med. 2020 Aug;111(4):300-302. doi: 10.23736/S0026-4806.20.06609-4. Epub 2020 May 14.
8
An oncologist perspective on COVID 19: A mysterious cryptic virus.肿瘤学家对新冠病毒的看法：一种神秘隐秘的病毒。
Oral Oncol. 2020 Jun;105:104694. doi: 10.1016/j.oraloncology.2020.104694. Epub 2020 Apr 11.
9
The Shifting Landscape of Genitourinary Oncology During the COVID-19 Pandemic and how Italian Oncologists Reacted: Results from a National Survey.新冠疫情期间泌尿生殖系统肿瘤领域的变化态势以及意大利肿瘤学家的应对举措：一项全国性调查结果
Eur Urol. 2020 Jul;78(1):e27-e35. doi: 10.1016/j.eururo.2020.04.004. Epub 2020 Apr 20.
10
Implications for COVID-19 triage from the ICNARC report of 2204 COVID-19 cases managed in UK adult intensive care units.英国成人重症监护病房管理的2204例新冠病毒病病例的ICNARC报告对新冠病毒病分诊的启示
Emerg Med J. 2020 Jun;37(6):332-333. doi: 10.1136/emermed-2020-209791. Epub 2020 May 4.

引用本文的文献

1
Recommendations for head and neck surgical procedures during the COVID-19 pandemic.COVID-19 大流行期间头颈部外科手术的建议。
Clinics (Sao Paulo). 2020;75:e2084. doi: 10.6061/clinics/2020/e2084. Epub 2020 Jul 6.
2
Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times.编辑辩论：在全民医疗体系下工作的我们肿瘤学家在这些艰难时期必须面对的挑战。
ESMO Open. 2020 May;5(3):e000800. doi: 10.1136/esmoopen-2020-000800.

本文引用的文献

1
Editorial debate: Challenges we oncologists, working within a universal healthcare system, have to face in these hard times.编辑辩论：在全民医疗体系下工作的我们肿瘤学家在这些艰难时期必须面对的挑战。
ESMO Open. 2020 May;5(3):e000800. doi: 10.1136/esmoopen-2020-000800.
2
COVID-19 and Italy: what next?COVID-19 和意大利：下一步如何？
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
3
Ethical prioritization of patients during disaster triage: A systematic review of current evidence.灾难分诊中患者的伦理优先排序：当前证据的系统评价
Int Emerg Nurs. 2019 Mar;43:126-132. doi: 10.1016/j.ienj.2018.10.004. Epub 2019 Jan 3.
4
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.欧洲药品管理局批准的癌症药物对总生存期和生活质量有益的证据可得性：2009 - 2013年药物批准情况的回顾性队列研究
BMJ. 2017 Oct 4;359:j4530. doi: 10.1136/bmj.j4530.
5
Why do our patients get chemotherapy until the end of life?为什么我们的患者直到生命尽头还在接受化疗？
Ann Oncol. 2011 Nov;22(11):2345-2348. doi: 10.1093/annonc/mdr416. Epub 2011 Sep 13.
6
Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.化疗后30天内的死亡率：肿瘤患者临床管理的基准问题。
Br J Cancer. 2006 Dec 18;95(12):1632-6. doi: 10.1038/sj.bjc.6603498.